Skip to main content
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: Mol Cancer Ther. 2016 May 9;15(7):1485–1494. doi: 10.1158/1535-7163.MCT-15-0566

Table 1.

List of upstream regulators related to MAPK signaling identified from pathway analysis of genes significantly modulated (>2 fold) after treatment with GS87 (30μM), Li (10mM) or SB (20μM) for 48 hours.

MAPK pathway – GS87
Upstream regulator Activation Fold Change p-value
SB203580 −5.84 5.43E-13
PD98059 −5.231 7.30E-26
U0126 −4.754 5.18E-15
SP600125 −3.885 1.92E-09
SB202190 −3.024 1.36E-10
MAPK10 2.197 1.37E-04
MAPK 2.287 6.33E-09
MAP2K1/2 2.365 6.66E-09
MAPK13 2.404 4.15E-04
MAPK12 2.418 2.17E-04
MAP3K7 2.494 1.23E-06
MAP2K3 2.760 1.10E-05
MAPK7 2.768 2.01E-05
MAPK3 3.056 1.45E-06
MAP2K1 3.092 4.83E-10
MAPK14 3.429 8.35E-04
MAP3K8 3.765 2.11E-06
ERK1/2 3.805 8.31E-11
ERK 3.961 8.06E-17
JNK 3.966 7.79E-07
MAPK pathway – SB
Upstream regulator Activation Fold Change p-value
U0126 -2.949 9.97E-07
LY294002 -2.681 6.23E-05
PD98059 -2.662 2.13E-05
SB203580 -2.153 2.32E-04
ERK 2.000 1.70E-05
MAPK pathway – Li
Upstream regulator Activation Fold Change p-value
JNK 2.221 4.88E-03
ERK 2.592 3.47E-04